Biosign Technologies Inc. Release: Notice of Annual General Meeting of Shareholders

Published: Aug 18, 2011

TORONTO, Aug. 17, 2011 /PRNewswire/ - Biosign Technologies Inc. (TSXV: BIO, the "Company") announces that its Annual General Meeting of Shareholders will be held at the office of Goodmans LLP, Suite 3400, Bay Adelaide Centre, 333 Bay Street, Toronto, Ontario, on September 12, 2011 at 11:00 a.m. (Toronto time) (the "Meeting") for the following purposes:

  1. to receive the audited financial statements of the Company for the fiscal year ended December 31, 2010 with auditor's report thereon;
  2. to fix the number of directors at six and to elect six directors for the ensuing year;
  3. to appoint the Company's auditor for the ensuing year;
  4. to confirm and reapprove the Company's "rolling 10%" stock option plan, as more particularly described in the accompanying Information Circular; and
  5. to transact such other business as may properly come before the Meeting or any adjournment thereof.

Steven Bloom is proposed to be a director in addition to the current five directors. Steven A. Bloom, a well-regarded accountant, is nominated to join the board and, if elected, is anticipated to Chair the Audit Committee. Mr. Bloom is currently the Senior Vice President, Finance for Kilmer Van Nostrand Co. Limited and has held positions as Chief Financial Officer at several private and public companies. Mr. Bloom obtained his Chartered Accountant and Certified Public Accountant and holds an Honours of Business Administration degree from the Richard Ivey School of Business at the University of Western Ontario.

Only shareholders of record at the close of business on August 8, 2011 will be entitled to receive notice of, and to vote at, the Meeting or any adjournment thereof. Shareholders who are unable to or who do not wish to attend the Meeting in person are requested to date and sign the enclosed Proxy form promptly and return it in the self-addressed envelope enclosed for that purpose or by any of the other methods indicated in the Proxy form. To be used at the Meeting, proxies must be received by Computershare Investor Services Inc., Proxy Department, 100 University Avenue, 9th Floor, Toronto, Ontario M5J 2Y1 by no later than 11:00 a.m. (Toronto time) on September 8, 2011 or, if the Meeting is adjourned, by no later than 11:00 a.m. (Toronto time) on the second last business day prior to the date on which the Meeting is reconvened, or may be deposited with the chairman of the Meeting prior to the commencement of the Meeting. If a registered shareholder receives more than one Proxy form because such shareholder owns shares registered in different names or addresses, each Proxy form should be completed and returned.

The related documents (Notice of Meeting, Information Circular, Proxy Form and Return Card) are available from SEDAR or the company's website (

About Biosign Technologies Inc.
Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT® medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Biosign Technologies Inc.

Back to news